Company / Free Cash Flow per Share
ARDELYX, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.18
FY2025
5-year range
-$1.65 / -$0.18
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#73 of 192
Health Care
What the data says
At $-0.18, ARDELYX, INC.'s free cash flow per share ranks #73 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-1.65 in FY2021 to $-0.18 in FY2025.
Based on SEC 10-K filings.
-0.18 in FY2025.
Improved from $-0.39 to $-0.18 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 192 in Health CareTop 38% of 192This company -$0.18 Sector average -$19.84
▼
+99.1% above sector average
Key checks
Key Insights
- ARDELYX, INC.'s free cash flow per share has grown for 4 consecutive years.
- In FY2025, free cash flow per share increased 6.5% year-over-year.
- Ranks #73 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.18 | +6.5% |
| FY2024 | -$0.19 | +50.3% |
| FY2023 | -$0.39 | +28.0% |
| FY2022 | -$0.54 | +67.4% |
| FY2021 | -$1.65 | -79.2% |
| FY2020 | -$0.92 | +25.1% |
| FY2019 | -$1.23 | +17.3% |
| FY2018 | -$1.48 | +6.7% |
| FY2017 | -$1.59 | -458.1% |
| FY2016 | $0.44 | +111.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026